Killer-cell immunoglobulin-like receptors (KIR) in severe A (H1N1) 2009 influenza infections.

Saray Aranda-Romo, Christian A Garcia-Sepulveda, Andreu Comas-García, Fernando Lovato-Salas, Mariana Salgado-Bustamante, Alejandro Gómez-Gómez, Daniel E Noyola
Author Information
  1. Saray Aranda-Romo: Departamento de Microbiología, Universidad Autónoma de San Luis Potosí, Avenida Venustiano Carranza #2405, Colonia los Filtros, 78210 San Luis Potosí, Mexico.

Abstract

Introduction of a novel influenza virus into the human population leads to the occurrence of pandemic events, such as the one caused by pandemic influenza A (H1N1) 2009 virus. The severity of infections caused by this virus in young adults was greater than that observed in patients with seasonal influenza. Fatal cases have been associated with an abnormal innate, proinflammatory immune response. A critical role for natural killer cells during the initial responses to influenza infections has been suggested. In this study, we assessed the association of killer-cell immunoglobulin-like receptors (KIRs) with disease severity by comparing KIR gene content in patients with mild and severe pandemic influenza virus infections to a control group. We found that activator (KIR3DS1 and KIR2DS5) and inhibitory (KIR2DL5) genes, encoded in group B haplotypes containing the cB01, cB03 and tB01 motifs, are associated with severe pandemic influenza A (H1N1) 2009 infections. Better understanding of how genetic variability contributes to influenza virus pathogenesis may help to the development of immune intervention strategies aiming at controlling the severity of disease.

References

  1. Genes Immun. 2005 Dec;6(8):683-90 [PMID: 16121209]
  2. Am J Transplant. 2008 Jun;8(6):1312-7 [PMID: 18444913]
  3. Tissue Antigens. 2007 Apr;69 Suppl 1:109-11 [PMID: 17445180]
  4. N Engl J Med. 2009 Aug 13;361(7):680-9 [PMID: 19564631]
  5. J Virol. 2008 May;82(10):4785-92 [PMID: 18305035]
  6. Curr Opin Immunol. 2005 Feb;17(1):29-35 [PMID: 15653307]
  7. Trends Microbiol. 2008 Dec;16(12):620-7 [PMID: 18976921]
  8. Cell Host Microbe. 2010 Jun 25;7(6):440-51 [PMID: 20542248]
  9. Immunol Rev. 2006 Dec;214:186-201 [PMID: 17100885]
  10. PLoS One. 2010 May 18;5(5):e10675 [PMID: 20502691]
  11. Nat Genet. 2007 Jun;39(6):733-40 [PMID: 17496894]
  12. CMAJ. 2010 Feb 23;182(3):257-64 [PMID: 20093297]
  13. Immunol Rev. 2001 Jun;181:20-38 [PMID: 11513141]
  14. Nat Genet. 2002 Aug;31(4):429-34 [PMID: 12134147]
  15. J Clin Virol. 2009 Jul;45(3):169-73 [PMID: 19540800]
  16. J Immunol. 2002 Mar 1;168(5):2307-15 [PMID: 11859120]
  17. Proc Biol Sci. 1998 Feb 7;265(1392):191-203 [PMID: 9493406]
  18. Science. 2004 Aug 6;305(5685):872-4 [PMID: 15297676]
  19. J Virol. 2009 Jul;83(13):6798-805 [PMID: 19386717]
  20. J Med Virol. 2011 Dec;83(12):2057-65 [PMID: 22012711]
  21. Expert Rev Mol Diagn. 2008 Jul;8(4):515-29 [PMID: 18598231]
  22. Tissue Antigens. 2007 Jul;70(1):34-41 [PMID: 17559579]
  23. J Clin Invest. 2004 Dec;114(12):1812-9 [PMID: 15599406]
  24. J Immunol. 1983 Dec;131(6):2699-704 [PMID: 6644021]
  25. J Med Virol. 2001 Jul;64(3):262-8 [PMID: 11424113]
  26. Crit Care Med. 2008 Sep;36(9):2660-6 [PMID: 18679129]
  27. Int Rev Immunol. 2001 Jun;20(3-4):333-70 [PMID: 11878509]
  28. Annu Rev Immunol. 2003;21:547-78 [PMID: 12524383]
  29. J Virol. 2010 May;84(9):4148-57 [PMID: 20164232]
  30. Immunogenetics. 2002 Aug;54(5):314-9 [PMID: 12185535]
  31. J Exp Med. 1993 Aug 1;178(2):597-604 [PMID: 8340759]
  32. PLoS One. 2011;6(9):e25060 [PMID: 21966414]
  33. BMC Infect Dis. 2010 Jun 10;10:164 [PMID: 20537158]
  34. Gastroenterology. 2010 Apr;138(4):1536-45 [PMID: 20080094]
  35. Mol Biol Rep. 2010 Apr;37(4):1883-90 [PMID: 19609718]
  36. J Immunol. 2006 Nov 15;177(10):6588-92 [PMID: 17082569]
  37. J Exp Med. 2007 Nov 26;204(12):3027-36 [PMID: 18025129]
  38. Clinics (Sao Paulo). 2010;65(12):1229-37 [PMID: 21340209]
  39. Immunogenetics. 2011 Sep;63(9):561-75 [PMID: 21638211]
  40. Emerg Infect Dis. 2010 Jan;16(1):27-34 [PMID: 20031039]
  41. Immunity. 1997 Dec;7(6):753-63 [PMID: 9430221]
  42. Immunogenetics. 2010 Dec;62(11-12):767-71 [PMID: 20878400]
  43. Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S60-8 [PMID: 21342901]
  44. J Virol. 2010 Aug;84(15):7822-31 [PMID: 20484512]
  45. Immunology. 2009 Oct;128(2):151-63 [PMID: 19740372]
  46. CMAJ. 2010 Mar 9;182(4):349-55 [PMID: 20159893]
  47. Tissue Antigens. 1996 Oct;48(4 Pt 1):278-84 [PMID: 8946681]
  48. PLoS One. 2011;6(12):e29200 [PMID: 22216211]
  49. JAMA. 2010 Apr 14;303(14):1383-91 [PMID: 20388894]
  50. J Immunol. 1996 May 1;156(9):3098-101 [PMID: 8617928]
  51. PLoS One. 2010 Dec 29;5(12):e15115 [PMID: 21206914]
  52. MMWR Morb Mortal Wkly Rep. 2009 Apr 24;58(15):400-2 [PMID: 19390508]
  53. J Leukoc Biol. 1989 Jul;46(1):75-83 [PMID: 2659714]
  54. J Reprod Immunol. 1999 Jul;43(2):157-65 [PMID: 10479051]
  55. Nucleic Acids Res. 2011 Jan;39(Database issue):D913-9 [PMID: 21062830]
  56. Blood. 2002 Feb 15;99(4):1289-98 [PMID: 11830478]
  57. Immunol Rev. 1997 Feb;155:205-21 [PMID: 9059896]
  58. J Clin Invest. 2008 Mar;118(3):1017-26 [PMID: 18246204]
  59. J Biomed Biotechnol. 2011;2011:451694 [PMID: 21960736]
  60. J Virol. 2010 Apr;84(8):4073-82 [PMID: 20130064]
  61. PLoS One. 2011 Feb 08;6(2):e16541 [PMID: 21346814]
  62. JAMA. 2010 Apr 21;303(15):1517-25 [PMID: 20407061]

MeSH Term

Adolescent
Adult
Aged
Amino Acid Motifs
Child
Child, Preschool
Female
Gene Frequency
Genotype
Haplotypes
Humans
Influenza A Virus, H1N1 Subtype
Influenza, Human
Male
Mexico
Middle Aged
Pandemics
Protein Isoforms
Receptors, KIR
Receptors, KIR2DL5
Receptors, KIR3DS1
Severity of Illness Index
Young Adult

Chemicals

KIR2DS5 protein, human
Protein Isoforms
Receptors, KIR
Receptors, KIR2DL5
Receptors, KIR3DS1

Word Cloud

Created with Highcharts 10.0.0influenzavirusinfectionspandemicH1N12009severityseverecausedpatientsassociatedimmuneimmunoglobulin-likereceptorsdiseaseKIRgroupIntroductionnovelhumanpopulationleadsoccurrenceeventsoneyoungadultsgreaterobservedseasonalFatalcasesabnormalinnateproinflammatoryresponsecriticalrolenaturalkillercellsinitialresponsessuggestedstudyassessedassociationkiller-cellKIRscomparinggenecontentmildcontrolfoundactivatorKIR3DS1KIR2DS5inhibitoryKIR2DL5genesencodedBhaplotypescontainingcB01cB03tB01motifsBetterunderstandinggeneticvariabilitycontributespathogenesismayhelpdevelopmentinterventionstrategiesaimingcontrollingKiller-cell

Similar Articles

Cited By